IO Biosciences is a company focused on developing allogeneic, gene modified cell therapies treating cancers. The company leverages a proprietary gene editing system and cell source, creating a unique opportunity to develop and manufacture of-the-shelf gene modified cell therapies.
Active Portfolio Company
http://iobiosciences.com/
Active Portfolio Company
http://iobiosciences.com/
Investors 1
| Date | Name | Website |
| - | BioAdvance | bioadvance... |
Mentions in press and media 1
| Date | Title | Description |
| 10.12.2020 | IO Biosciences Awarded US Patent for GEMSTM Technology, Promising Breakthrough for Those Engineering Antibody Therapies and Therapeutic Gene-modified Immune Cells | IO Biosciences, Inc., announced today that it has been awarded its first patent for nucleic acid constructs comprising gene-editing multi-sites (GEMS) and their uses. This patent represents a departure from traditional viral gene editing me... |